Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine

Fampridine response in MS patients with gait impairment in a real-world setting: Need for new response criteria?

(2017) Francisco Alejandro Rodriguez-Leal et al.   Multiple Sclerosis Journal

Monitoring long-term efficacy of fampridine in gait-impaired patients with multiple sclerosis

(2017) Linard Filli et al.   NEUROLOGY

Fampridine response in MS patients with gait impairment in a real-world setting: Need for new response criteria?

(2017) Francisco Alejandro Rodriguez-Leal et al.   Multiple Sclerosis Journal

Prolonged-release fampridine treatment improved subject-reported impact of multiple sclerosis: Item-level analysis of the MSIS-29

(2016) Claudio Gasperini et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern

(2016) Björn Zörner et al.   Multiple Sclerosis Journal

Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern

(2016) Björn Zörner et al.   Multiple Sclerosis Journal

Absolute and Relative Reliability of the Timed ‘Up & Go’ Test and ‘30second Chair-Stand’ Test in Hospitalised Patients with Stroke

(2016) Katrine Lyders Johansen et al.   PLoS One

Sustained-released fampridine in multiple sclerosis: effects on gait parameters, arm function, fatigue, and quality of life

(2015) Etienne Allart et al.   JOURNAL OF NEUROLOGY

Unilateral and bilateral upper limb dysfunction at body functions, activity and participation levels in people with multiple sclerosis

(2015) Rita Bertoni et al.   Multiple Sclerosis Journal

Lending a hand: Can DASH items help ABILHAND improve manual ability measurement in multiple sclerosis?

(2015) Louise Barrett et al.   Multiple Sclerosis Journal

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials

(2015) Andrew D Goodman et al.   Multiple Sclerosis Journal

Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial

(2015) Raymond Hupperts et al.   Multiple Sclerosis Journal

Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine

(2015) Richard Macdonell et al.   Multiple Sclerosis Journal

Assessment of confirmed urinary tract infection in patients treated with dalfampridine for multiple sclerosis

(2015) Daniel Kantor et al.   POSTGRADUATE MEDICINE

Unilateral and bilateral upper limb dysfunction at body functions, activity and participation levels in people with multiple sclerosis

(2015) Rita Bertoni et al.   Multiple Sclerosis Journal

Lending a hand: Can DASH items help ABILHAND improve manual ability measurement in multiple sclerosis?

(2015) Louise Barrett et al.   Multiple Sclerosis Journal

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials

(2015) Andrew D Goodman et al.   Multiple Sclerosis Journal

Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial

(2015) Raymond Hupperts et al.   Multiple Sclerosis Journal

Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine

(2015) Richard Macdonell et al.   Multiple Sclerosis Journal

Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods

(2014) J Hobart et al.   HEALTH TECHNOLOGY ASSESSMENT

Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening

(2014) Glenn A Phillips et al.   Multiple Sclerosis Journal

Ambulatory Activity in Individuals With Multiple Sclerosis

(2013) James T. Cavanaugh et al.   Journal of Neurologic Physical Therapy

Can the ABILHAND handle manual ability in MS?

(2012) LE Barrett et al.   Multiple Sclerosis Journal

Assessing walking disability in multiple sclerosis

(2012) Bernd C. Kieseier et al.   Multiple Sclerosis Journal

Reliability and clinical significance of mobility and balance assessments in multiple sclerosis

(2012) Yvonne C. Learmonth et al.   INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH

Validity, Responsiveness, and Clinically Important Difference of the ABILHAND Questionnaire in Patients With Stroke

(2011) Tien-ni Wang et al.   ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION

Dalfampridine: a brief review of its mechanism of action and efficacy as a treatment to improve walking in patients with multiple sclerosis

(2011) Jeffrey Dunn et al.   CURRENT MEDICAL RESEARCH AND OPINION

Generic ABILHAND questionnaire can measure manual ability across a variety of motor impairments

(2011) Anna Simone et al.   INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH

A phase 3 trial of extended release oral dalfampridine in multiple sclerosis

(2010) Andrew D. Goodman et al.   ANNALS OF NEUROLOGY

Responsiveness of the ABILHAND questionnaire in measuring changes in rheumatoid arthritis patients

(2010) Charles Sèbiyo Batcho et al.   ARTHRITIS CARE & RESEARCH

Contribution of impaired mobility to patient burden in multiple sclerosis

(2009) Matthew H. Sutliff   CURRENT MEDICAL RESEARCH AND OPINION

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

(2009) Andrew D Goodman et al.   LANCET

Placebo effects: clinical aspects and neurobiology

(2008) B. S. Oken   BRAIN

Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable

(2008) C Heesen et al.   Multiple Sclerosis Journal

Use of the Berg Balance Scale for Predicting Multiple Falls in Community-Dwelling Elderly People: A Prospective Study

(2008) Susan W Muir et al.   PHYSICAL THERAPY

Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations

(2007) Robert H. Dworkin et al.   JOURNAL OF PAIN